Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716
Top Cited Papers
- 1 April 2001
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 58 (4), 322-8
- https://doi.org/10.1001/archpsyc.58.4.322
Abstract
SR141716, a recently developed CB1 cannabinoid receptor antagonist, blocks acute effects of Delta-9-tetrahydrocannabinol (THC) and other CB1 cannabinoid agonists in vitro and in animals. These findings suggest that CB1 receptors mediate many of the effects of marijuana, but this has not been evaluated in humans. Sixty-three healthy men with a history of marijuana use were randomly assigned to receive oral SR141716 or a placebo in an escalating dose (1, 3, 10, 30, and 90 mg) design. Each subject smoked an active (2.64% THC) or placebo marijuana cigarette 2 hours later. Psychological effects associated with marijuana intoxication and heart rate were measured before and after antagonist and marijuana administration. Single oral doses of SR141716 produced a significant dose-dependent blockade of marijuana-induced subjective intoxication and tachycardia. The 90-mg dose produced 38% to 43% reductions in visual analog scale ratings of "How high do you feel now?" "How stoned on marijuana are you now?" and "How strong is the drug effect you feel now?" and produced a 59% reduction in heart rate. SR141716 alone produced no significant physiological or psychological effects and did not affect peak THC plasma concentration or the area under the time x concentration curve. SR141716 was well tolerated by all subjects. SR141716 blocked acute psychological and physiological effects of smoked marijuana without altering THC pharmacokinetics. These findings confirm, for the first time in humans, the central role of CB1 receptors in mediating the effects of marijuana.Keywords
This publication has 28 references indexed in Scilit:
- Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout MiceScience, 1999
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Comparative Effects of Alcohol and Marijuana on Mood, Memory, and PerformancePharmacology Biochemistry and Behavior, 1997
- Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptorBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1996
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Characterization of the absorption phase of marijuana smokingClinical Pharmacology & Therapeutics, 1992
- Molecular cloning of a human cannabinoid receptor which is also expressed in testisBiochemical Journal, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990